Scientific publications

Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells

Sep 26, 2016 | Magazine: PLoS One

Acanda de la Rocha AM (1,2,3), López-Bertoni H (4,5), Guruceaga E (1,6), González-Huarriz M (1,2,3), Martínez-Vélez N (1,2,3), Xipell E (1,2,3), Fueyo J (7), Gomez-Manzano C (7), Alonso MM (1,2,3).

Glioblastoma is the most malignant brain tumor in adults and is associated with poor survival despite multimodal treatments. Glioma stem-like cells (GSCs) are cells functionally defined by their self-renewal potential and the ability to reconstitute the original tumor upon orthotopic implantation.

They have been postulated to be the culprit of glioma chemo- and radio-resistance ultimately leading to relapse. Understanding the molecular circuits governing the GSC compartment is essential. SOX2, a critical transcription regulator of embryonic and neural stem cell function, is deregulated in GSCs however; the precise molecular pathways regulated by this gene in GSCs remain poorly understood.

We performed a genome-wide analysis of SOX2-regulated transcripts in GSCs, using a microarray. We identified a total of 2048 differentially expressed coding transcripts and 261 non-coding transcripts. Cell adhesion and cell-cell signaling are among the most enriched terms using Gene Ontology (GO) classification.

The pathways altered after SOX2 down-modulation includes multiple cellular processes such as amino-acid metabolism and intercellular signaling cascades. We also defined and classified the set of non-coding transcripts differentially expressed regulated by SOX2 in GSCs, and validated two of them.

We present a comprehensive analysis of the transcriptome controlled by SOX2 in GSCs, gaining insights in the understanding of the potential roles of SOX2 in glioblastoma.

CITATION  PLoS One. 2016 Sep 26;11(9):e0163155. doi: 10.1371/journal.pone.0163155

Our authors